The use of nanotechnology in cardiovascular disease

Meera Chandarana, Anthony Curtis, Clare Hoskins

Research output: Contribution to journalReview articlepeer-review

64 Citations (Scopus)
69 Downloads (Pure)


Cardiovascular diseases claim a number of lives globally; many of which are preventable. With the increase in diets that consist of high saturated fat, salt, and sugar, people often living sedentary lifestyles, and a rise in cases of obesity, the incidence of cardiovascular disease is increasing. These contributing factors, coupled with more advanced methods of diagnosis, have delivered statistics that clearly show that there is a rising trend in the prevalence of cardiovascular disease. Treatment for cardiovascular diseases is limited currently to oral medicines or invasive surgery. There is a huge gap in this area of medicine for novel therapeutics for improved patient outcomes. Nanotechnology may provide a solution to more effective treatment of disease, with better prognoses and a reduced side effect profile. This review will explore for potential solutions to the limited pharmacological therapies currently on the market and the future that lies ahead for the place of nanotechnology within cardiovascular medicine.
Original languageEnglish
Pages (from-to)1607–1619
Number of pages13
JournalApplied Nanoscience
Issue number7
Publication statusPublished - 16 Aug 2018


  • nanomedicine
  • medical therapeutics
  • nanotechnology
  • cardiovascular disease


Dive into the research topics of 'The use of nanotechnology in cardiovascular disease'. Together they form a unique fingerprint.

Cite this